Utilizamos cookies propias y de terceros para identificar la sesión del usuario y mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Si continúa navegando por el sitio web manifiesta consentir su instalación y uso conforme lo anterior. Puede cambiar la configuración y obtener más información aquí.

Bibliografía científicaBibliografía científica

En esta sección encontrará una selección de las publicaciones científicas sobre los Trastornos del Movimiento para los 11 diferentes tipos establecidos por la International Parkinson & Movement Disorder Society. Se han seleccionado sólo aquellas publicaciones que presenten el término de búsqueda en el título (inglés).

Los artículos presentados incluyen aquellos publicados desde enero de 2010. El listado de publicaciones de actualizará mensualmente. Si lo desea, puede recibir una alerta de la actualización por correo electrónico. Para ello ha de registrarse.

Resúmenes publicados
Búsqueda
Enfermedad de Parkinson y Parkinsonismo Parkinson’s disease & Parkinsonism 1392 artículos Viendo del 1 al 40 de 1392 artículos
Pub MED

Clinical implications of early caudate dysfunction in Parkinson's disease.NUEVO

Pasquini J, Durcan R, Wiblin L, Gersel Stokholm M, Rochester L, Brooks DJ, Burn D, Pavese N.
J Neurol Neurosurg Psychiatry. 2019 Oct;90(10):1098-1104. doi: 10.1136/jnnp-2018-320157. Epub 2019 May 11.
Pub MED

Purinergic Signalling in Parkinson's Disease: A Multi-target System to Combat Neurodegeneration.NUEVO

Tóth A, Antal Z, Bereczki D, Sperlágh B.
Neurochem Res. 2019 Oct;44(10):2413-2422. doi: 10.1007/s11064-019-02798-1. Epub 2019 May 4.
Pub MED

Inflammatory process in Parkinson disease: neuroprotection by neuropeptide Y.NUEVO

Pain S, Vergote J, Gulhan Z, Bodard S, Chalon S, Gaillard A.
Fundam Clin Pharmacol. 2019 Oct;33(5):544-548. doi: 10.1111/fcp.12464. Epub 2019 Apr 1.
Pub MED

The early diagnosis of Parkinson's disease through combined biomarkers.NUEVO

Chen XQ, Niu JP, Peng RQ, Song YH, Xu N, Zhang YW.
Acta Neurol Scand. 2019 Oct;140(4):268-273. doi: 10.1111/ane.13140. Epub 2019 Jun 13.
Pub MED

Proteomics in Human Parkinson's Disease: Present Scenario and Future Directions.NUEVO

Dixit A, Mehta R, Singh AK.
Cell Mol Neurobiol. 2019 Oct;39(7):901-915. doi: 10.1007/s10571-019-00700-9. Epub 2019 Jun 12. Review.
Pub MED

Identification of miRNA-7 as a regulator of brain-derived neurotrophic factor/α-synuclein axis in atrazine-induced Parkinson's disease by peripheral blood and brain microRNA profiling.NUEVO

Li B, Jiang Y, Xu Y, Li Y, Li B.
Chemosphere. 2019 Oct;233:542-548. doi: 10.1016/j.chemosphere.2019.05.064. Epub 2019 May 23.
Pub MED

Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus.NUEVO

Black KJ, Nasrallah H, Isaacson S, Stacy M, Pahwa R, Adler CH, Alva G, Cooney JW, Kremens D, Menza MA, Meyer JM, Patkar AA, Simuni T, Morrissette DA, Stahl SM.
CNS Spectr. 2019 Oct;24(5):574-575. doi: 10.1017/S1092852919000932. No abstract available.
Pub MED

Invasive and Noninvasive Brain Stimulation in Parkinson's Disease: Clinical Effects and Future Perspectives.NUEVO

Chen KS, Chen R.
Clin Pharmacol Ther. 2019 Oct;106(4):763-775. doi: 10.1002/cpt.1542. Epub 2019 Jul 22. Review.
Pub MED

Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson's disease.NUEVO

Specketer K, Zabetian CP, Edwards KL, Tian L, Quinn JF, Peterson-Hiller AL, Chung KA, Hu SC, Montine TJ, Cholerton BA.
J Clin Exp Neuropsychol. 2019 Oct;41(8):803-813. doi: 10.1080/13803395.2019.1623180. Epub 2019 Jun 10.
Pub MED

How do Parkinson's disease patients manage Ramadan fasting? An observational study.NUEVO

Kamel WA, Al Hashel JY, Damier P.
Rev Neurol (Paris). 2019 Oct;175(9):560-563. doi: 10.1016/j.neurol.2018.12.008. Epub 2019 Jun 5.
Pub MED

A secret that underlies Parkinson's disease: The damaging cycle.NUEVO

Sun F, Deng Y, Han X, Liu Q, Zhang P, Manzoor R, Ma H.
Neurochem Int. 2019 Oct;129:104484. doi: 10.1016/j.neuint.2019.104484. Epub 2019 Jun 4. Review.
Pub MED

A different view on the pathophysiology of Parkinson's disease: a descendent neurochemical hypothesis?NUEVO

Yulug B, Ozansoy M, Cankaya S.
Neural Regen Res. 2019 Oct;14(10):1717-1718. doi: 10.4103/1673-5374.257527. No abstract available.
Pub MED

The role of LRRK2 on PKA-NFκB pathway in microglia cells: implications for Parkinson's disease.NUEVO

Russo I.
Neural Regen Res. 2019 Oct;14(10):1713-1714. doi: 10.4103/1673-5374.257523. No abstract available.
Pub MED

Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.NUEVO

Wegrzynowicz M, Bar-On D, Calo' L, Anichtchik O, Iovino M, Xia J, Ryazanov S, Leonov A, Giese A, Dalley JW, Griesinger C, Ashery U, Spillantini MG.
Acta Neuropathol. 2019 Oct;138(4):575-595. doi: 10.1007/s00401-019-02023-x. Epub 2019 May 31.
Pub MED

Neuroprotective attributes of L-theanine, a bioactive amino acid of tea, and its potential role in Parkinson's disease therapeutics.NUEVO

Deb S, Dutta A, Phukan BC, Manivasagam T, Justin Thenmozhi A, Bhattacharya P, Paul R, Borah A.
Neurochem Int. 2019 Oct;129:104478. doi: 10.1016/j.neuint.2019.104478. Epub 2019 May 27. Review.
Pub MED

Effects of Parkinson's disease on molar bite force, electromyographic activity and muscle thickness of the masseter, temporal and sternocleidomastoid muscles: A case-control study.NUEVO

Donizetti Verri E, da Silva GP, Marianetti Fioco E, Soares da Silva N, Valin Fabrin SC, Augusto Bueno Zanella C, Roberta Garrefa C, Faria Júnior M, Siéssere S, Hallak JEC, Palinkas M, Chaves TC, Regalo SCH.
J Oral Rehabil. 2019 Oct;46(10):912-919. doi: 10.1111/joor.12824. Epub 2019 Jun 17.
Pub MED

Emotional valence may influence memory performance for visual artworks in Parkinson's disease.NUEVO

Ciccarelli N, Di Tella S, Lo Monaco MR, Carfì A, Serafini E, Delle Donne V, Silveri MC.
Neurol Sci. 2019 Oct;40(10):2175-2178. doi: 10.1007/s10072-019-03939-8. Epub 2019 May 29.
Pub MED

Anxiety-like behavior induced by 6-OHDA animal model of Parkinson's disease may be related to a dysregulation of neurotransmitter systems in brain areas related to anxiety.NUEVO

Vieira JCF, Bassani TB, Santiago RM, de O Guaita G, Zanoveli JM, da Cunha C, Vital MABF.
Behav Brain Res. 2019 Oct 3;371:111981. doi: 10.1016/j.bbr.2019.111981. Epub 2019 May 26.
Pub MED

Role of chemokines in Parkinson's disease.NUEVO

Liu JQ, Chu SF, Zhou X, Zhang DY, Chen NH.
Brain Res Bull. 2019 Oct;152:11-18. doi: 10.1016/j.brainresbull.2019.05.020. Epub 2019 May 25. Review.
Pub MED

The Parkinson-associated human P5B-ATPase ATP13A2 modifies lipid homeostasis.NUEVO

Marcos AL, Corradi GR, Mazzitelli LR, Casali CI, Fernández Tome MDC, Adamo HP, de Tezanos Pinto F.
Biochim Biophys Acta Biomembr. 2019 Oct 1;1861(10):182993. doi: 10.1016/j.bbamem.2019.05.015. Epub 2019 May 24.
Pub MED

Regional gray matter reductions associated with mild cognitive impairment in Parkinson's disease: A meta-analysis of voxel-based morphometry studies.NUEVO

Zheng D, Chen C, Song W, Yi Z, Zhao P, Zhong J, Dai Z, Shi H, Pan P.
Behav Brain Res. 2019 Oct 3;371:111973. doi: 10.1016/j.bbr.2019.111973. Epub 2019 May 22.
Pub MED

Detection of orthostatic hypotension with ambulatory blood pressure monitoring in parkinson's disease.NUEVO

Vallelonga F, Romagnolo A, Merola A, Sobrero G, Di Stefano C, Milazzo V, Burrello J, Burrello A, Zibetti M, Milan A, Veglio F, Maule S.
Hypertens Res. 2019 Oct;42(10):1552-1560. doi: 10.1038/s41440-019-0267-x. Epub 2019 May 22.
Pub MED

Ages at Onset of Anxiety and Depressive Disorders in Parkinson's Disease.NUEVO

Seritan AL, Rienas C, Duong T, Delucchi K, Ostrem JL.
J Neuropsychiatry Clin Neurosci. 2019 Fall;31(4):346-352. doi: 10.1176/appi.neuropsych.18090201. Epub 2019 May 23.
Pub MED

Psychometric properties of clock and pelvic drawings in Parkinson's disease: A validity and cross-sectional study.NUEVO

Abraham A, Wright GN, Morrison MW, Hart A, Dickstein R, Hackney ME.
Physiother Res Int. 2019 Oct;24(4):e1781. doi: 10.1002/pri.1781. Epub 2019 May 14.
Pub MED

Using PROMs during routine medical consultations: The perspectives of people with Parkinson's disease and their health professionals.NUEVO

Damman OC, Verbiest MEA, Vonk SI, Berendse HW, Bloem BR, de Bruijne MC, Faber MJ.
Health Expect. 2019 Oct;22(5):939-951. doi: 10.1111/hex.12899. Epub 2019 Jun 14.
Pub MED

Sleep deprivation caused a memory defects and emotional changes in a rotenone-based zebrafish model of Parkinson's disease.NUEVO

Lv DJ, Li LX, Chen J, Wei SZ, Wang F, Hu H, Xie AM, Liu CF.
Behav Brain Res. 2019 Oct 17;372:112031. doi: 10.1016/j.bbr.2019.112031. Epub 2019 Jun 10.
Pub MED

Destroyed non-dopaminergic pathways in the early stage of Parkinson's disease assessed by posturography.NUEVO

Halmi Z, Dinya E, Málly J.
Brain Res Bull. 2019 Oct;152:45-51. doi: 10.1016/j.brainresbull.2019.07.001. Epub 2019 Jul 8.
Pub MED

Evaluation of oxidative stress mechanisms and the effects of phytotherapic extracts on Parkinson's disease Drosophila PINK1B9 model.NUEVO

Baroli B, Loi E, Solari P, Kasture A, Moi L, Muroni P, Kasture S, Setzu MD, Liscia A, Zavattari P.
FASEB J. 2019 Oct 1;33(10):11028-11034. doi: 10.1096/fj.201901010. Epub 2019 Jul 10.
Pub MED

Dopaminergic modulation of motor network compensatory mechanisms in Parkinson's disease.NUEVO

Jastrzębowska MA, Marquis R, Melie-García L, Lutti A, Kherif F, Herzog MH, Draganski B.
Hum Brain Mapp. 2019 Oct 15;40(15):4397-4416. doi: 10.1002/hbm.24710. Epub 2019 Jul 10.
Pub MED

The challenge of pain in the pharmacological management of Parkinson's disease.NUEVO

Jost WH, Buhmann C.
Expert Opin Pharmacother. 2019 Oct;20(15):1847-1854. doi: 10.1080/14656566.2019.1639672. Epub 2019 Jul 10.
Pub MED

Kir6.1/K-ATP channel on astrocytes protects against dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease via promoting mitophagy.NUEVO

Hu ZL, Sun T, Lu M, Ding JH, Du RH, Hu G.
Brain Behav Immun. 2019 Oct;81:509-522. doi: 10.1016/j.bbi.2019.07.009. Epub 2019 Jul 6.
Pub MED

Predictive potential of preoperative electroencephalogram for neuropsychological change following subthalamic nucleus deep brain stimulation in Parkinson's disease.NUEVO

Yakufujiang M, Higuchi Y, Aoyagi K, Yamamoto T, Abe M, Okahara Y, Izumi M, Nagano O, Yamanaka Y, Hirano S, Shiina A, Murata A, Iwadate Y.
Acta Neurochir (Wien). 2019 Oct;161(10):2049-2058. doi: 10.1007/s00701-019-03991-5. Epub 2019 Jul 5.
Pub MED

Cognitive complaints in Parkinson's disease patients: from subjective cognitive complaints to dementia and affective disorders.NUEVO

Barbosa RP, Mendonça MD, Caetano AP, Lampreia TM, Miguel R, Bugalho PM.
J Neural Transm (Vienna). 2019 Oct;126(10):1329-1335. doi: 10.1007/s00702-019-02042-8. Epub 2019 Jul 5.
Pub MED

Expression of tyrosine hydroxylase isoforms and phosphorylation at serine 40 in the human nigrostriatal system in Parkinson's disease.NUEVO

Shehadeh J, Double KL, Murphy KE, Bobrovskaya L, Reyes S, Dunkley PR, Halliday GM, Dickson PW.
Neurobiol Dis. 2019 Oct;130:104524. doi: 10.1016/j.nbd.2019.104524. Epub 2019 Jul 2.
Pub MED

Deep brain stimulation for Parkinson's disease modulates high-frequency evoked and spontaneous neural activity.NUEVO

Sinclair NC, McDermott HJ, Fallon JB, Perera T, Brown P, Bulluss KJ, Thevathasan W.
Neurobiol Dis. 2019 Oct;130:104522. doi: 10.1016/j.nbd.2019.104522. Epub 2019 Jul 2.
Pub MED

Toll-like receptors and their therapeutic potential in Parkinson's disease and α-synucleinopathies.NUEVO

Kouli A, Horne CB, Williams-Gray CH.
Brain Behav Immun. 2019 Oct;81:41-51. doi: 10.1016/j.bbi.2019.06.042. Epub 2019 Jul 2. Review.
Pub MED

MicroRNA-326 Inhibits Apoptosis and Promotes Proliferation of Dopaminergic Neurons in Parkinson's Disease Through Suppression of KLK7-Mediated MAPK Signaling Pathway.NUEVO

Zhang Y, Xu W, Nan S, Chang M, Fan J.
J Mol Neurosci. 2019 Oct;69(2):197-214. doi: 10.1007/s12031-019-01349-1. Epub 2019 Jul 3.
Pub MED

The PRIAMO study: active sexual life is associated with better motor and non-motor outcomes in men with early Parkinson's disease.NUEVO

Picillo M, Palladino R, Erro R, Colosimo C, Marconi R, Antonini A, Barone P; PRIAMO study group..
Eur J Neurol. 2019 Oct;26(10):1327-1333. doi: 10.1111/ene.13983. Epub 2019 Jul 2.
Pub MED

Unequivocal Biomarker for Parkinson's Disease: A Hunt that Remains a Pester.NUEVO

Sarkar A, Rawat N, Sachan N, Singh MP.
Neurotox Res. 2019 Oct;36(3):627-644. doi: 10.1007/s12640-019-00080-4. Epub 2019 Jul 2. Review.
Pub MED

Prospective memory in Parkinson's disease: the role of the motor subtypes.NUEVO

D'Iorio A, Maggi G, Vitale C, Amboni M, Di Meglio D, Trojano L, Santangelo G.
J Neurol. 2019 Oct;266(10):2505-2511. doi: 10.1007/s00415-019-09448-0. Epub 2019 Jun 29.
Viendo del 1 al 40 de 1392 artículos
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:

Sociedad Española de Neurología

Sociedad Española
de Neurología
En colaboración con:

Zambon

Haga click en el logo para acceder
a información acerca de Zambon
NeuroAcademy